Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minimum Effective Dose of Intrathecal Ropivacaine for Cesarean Delivery
NCT02565303Completed
- Sponsor
- Shanghai Sixth People's Hospital
- Start
- Sep 2015
- Primary completion
- May 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, single-blind trial of ropivacaine (2 arms), sponsored by Shanghai Sixth People's Hospital. Primary endpoint: Sensory block assessment evaluated with visual analogue scale (VAS) and sensory dermatomal anesthesia. Started Sep 2015; status: completed.
02
Drugs
ropivacaine
Beyond the preview
Go deeper on NCT02565303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02565303.